| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |